The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management
Tóm tắt
Từ khóa
Tài liệu tham khảo
•• GLOBOCAN. Estimated number of colorectal cancer new cases in 2018, worldwide, both sexes, all ages Cancer Today 2018 [cited 2018 October,19, 2018]; Available from: https://gco.iarc.fr/today/online-analysis-table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=5&group_cancer=1&include_nmsc=1&include_nmsc_other=1 . This brought out the latest updates of the burden of colorectal cancer in Asia and the rest of the world.
GLOBOCAN. Colorectal Cancer. 2018. 2.
•• Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49. It identified the various global CRC screening programs.
Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009;101:1412–22.
Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23:3632–42.
•• Lee YC, Hsu CY, Chen SL, Yen AM, Chiu SY, Fann JC, et al. Effects of screening and universal healthcare on long-term colorectal cancer mortality. Int J Epidemiol. 2018;48:538–48. Much improvement in CRC survival as a result of universal healthcare coverage.
Ghoncheh M, Mohammadian M, Mohammadian-Hafshejani A, Salehiniya H. The incidence and mortality of colorectal cancer and its relationship with the human development index in Asia. Ann Glob Health. 2016;82:726–37.
Wu CY. In 2015 about every five minutes, one person in Taiwan was diagnosed with cancer. Taiwan’s national cancer diagnosis has been on the rise 2017 [cited 2019 January 7]; Available from: https://www.taiwannews.com.tw/en/news/3330583 .
Boyle P, Zaridze DG, Smans M. Descriptive epidemiology of colorectal cancer. Int J Cancer. 1985;36:9–18.
Yee YK, Tan VP, Chan P, Hung IF, Pang R, Wong BC. Epidemiology of colorectal cancer in Asia. J Gastroenterol Hepatol. 2009;24:1810–6.
•• Park S, Jee SH, Epidemiology of colorectal cancer in Asia-Pacific region, in surgical treatment of colorectal cancer. 2018, Springer: Singapore. 3-10. Current information on CRC epidemiology in Asia.
Abu Hassan MR, Ismail I, Mohd Suan MA, Ahmad F, Wan Khazim WK, Othman Z, et al. Incidence and mortality rates of colorectal cancer in Malaysia. Epidemiol Health. 2016;38:e2016007.
Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22:191–7.
Kokki I, Papana A, Campbell H, Theodoratou E. Estimating the incidence of colorectal cancer in South East Asia. Croat Med J. 2013;54:532–40.
Sung JJY, Chiu HM, Jung KW, Jun JK, Sekiguchi M, Matsuda T, et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am J Gastroenterol. 2019;114:322–9.
Asia Pacific Cohort Studies C, Huxley R, Ansary-Moghaddam A, Huxley R, Lam TH, Ueshima H, et al. The role of lifestyle risk factors on mortality from colorectal cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev. 2007;8:191–8.
Konishi T, Watanabe T, Muto T, Kotake K, Nagawa H, Japanese Society for Cancer of the C, et al. Difference in incidence of colorectal cancer between men and women in Asia. Lancet Oncol. 2006;7:104–5.
Pourhoseingholi MA. Epidemiology and burden of colorectal cancer in Asia-Pacific region: what shall we do now? Transl Gastrointest Cancer. 2014;3:169–73.
•• Chiu HM, Hsu WF, Chang LC, Wu MH. Colorectal cancer screening in Asia. Curr Gastroenterol Rep. 2017;19:47. It brought out the activities and some constraints of CRC screening in Asia.
Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu C, Li Y. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62:235–43.
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.
• Koo JH, Leong RW, Ching J, Yeoh KG, Wu DC, Murdani A, et al. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc. 2012;76:126–35. The only multi-national survey on knowledge and attitude toward CRC screening in the Asian population.
Hilmi I, Hartono JL, Goh K. Negative perception in those at highest risk--potential challenges in colorectal cancer screening in an urban Asian population. Asian Pac J Cancer Prev. 2010;11:815–22.
Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S. Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol. 2008;103:974–81.
Wong MC, Ching JY, Hirai HH, Lam TY, Griffiths SM, Chan FK, et al. Perceived obstacles of colorectal cancer screening and their associated factors among 10,078 Chinese participants. PLoS One. 2013;8:e70209.
Farooqui M, Hassali MA, Knight A, Shafie AA, Farooqui MA, Saleem F, et al. A qualitative exploration of Malaysian cancer patients’ perceptions of cancer screening. BMC Public Health. 2013;13:48.
Javadzade SH, Reisi M, Mostafavi F, Heydarabadi AB, Tavassoli E, Sharifirad G. Barriers related to fecal occult blood test for colorectal cancer screening in moderate risk individuals. J Educ Health Promot. 2014;3:120.
Loh KW, Majid HA, Dahlui M, Roslani AC, Su TT. Sociodemographic predictors of recall and recognition of colorectal cancer symptoms and anticipated delay in help-seeking in a multiethnic Asian population. Asian Pac J Cancer Prev. 2013;14:3799–804.
Yusoff HM, Daud N, Noor NM, Rahim AA. Participation and barriers to colorectal cancer screening in Malaysia. Asian Pac J Cancer Prev. 2012;13:3983–7.
Hashim SM, Omar K, Fah TS, Rashid RA, Daud TI, Shah SA, et al. Factors influencing late consultation among patients with rectal bleeding in University Kebangsaan Malaysia Medical Centre. Asian Pac J Cancer Prev. 2010;11:1335–9.
Kong CK, Roslani AC, Law CW, Law SC, Arumugam K. Impact of socio-economic class on colorectal cancer patient outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pac J Cancer Prev. 2010;11:969–74.
Sano Y, Byeon JS, Li XB, Wong MC, Chiu HM, Rerknimitr R, et al. Colorectal cancer screening of the general population in East Asia. Dig Endosc. 2016;28:243–9.
Sung JJ, Lau JY, Goh KL, Leung WK, Asia Pacific Working Group on Colorectal C. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–6.
Wong MC, John GK, Hirai HW, Lam TY, Luk AK, Ching JY, et al. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control. 2012;23:1541–8.
• Chiu HM, Chang LC, Hsu WF, Chou CK, Wu MS. Non-invasive screening for colorectal cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29:953–65. The non-invasive screening tools remain the appropriate tools for CRC screening in Asia.
Cai SR, Zhang SZ, Zhu HH, Zheng S. Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol. 2009;15:2531–6.
Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol. 2012;27:1070–7.
• Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015;64:121–32. Latest CRC screening recommendations for Asia-Pacific.
Sollano JD, Lontok M, de Lusong MAA, Romano RP, Macatula TC, Payawal DA, et al. The joint Philippine Society of Gastroenterology (PSG) and Philippine Society of Digestive Endoscopy (PSDE) consensus guidelines on the management of colorectal carcinoma. Philipp J Intern Med. 2017;55:1–16.
Tsoi KK, Ng SS, Leung MC, Sung JJ. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Aliment Pharmacol Ther. 2008;28:353–63.
•• Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88–100. Comprehensive review of current decision analysis research on CRC screening.
Benard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24:124–38.
Geiger TM, Ricciardi R. Screening options and recommendations for colorectal cancer. Clin Colon Rectal Surg. 2009;22:209–17.
Janz T, Lu K, Povlow MR, Urso B. A review of colorectal cancer detection modalities, stool DNA, and fecal immunochemistry testing in adults over the age of 50. Cureus. 2016;8:e931.
Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.
Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, et al. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol. 2017;112:1728–35.
van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.
Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–82.
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–81.
Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328:901–6.
Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96.
Cheng SY, Li MC, Chia SL, Huang KC, Chiu TY, Chan DC, et al. Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program. Cancer. 2018;124:907–15.
Chiu HM, Chen HH. Reply to Screening for colorectal cancer in Taiwan and France: does the fecal immunochemical test (FIT) fit? Cancer. 2015;121:4442–3.
Provenzale D, Gray RN. Colorectal cancer screening and treatment: review of outcomes research. J Natl Cancer Inst Monogr. 2004;2004:45–55.
Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–105.
Ahmed F. Barriers to colorectal cancer screening in the developing world: the view from Pakistan. World J Gastrointest Pharmacol Ther. 2013;4:83–5.
Gelband H, Jha P, Sankaranarayanan R, Horton S, Bank W. Disease control priorities, third edition (volume 3): cancer. 2015; Available from: http://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=4397350 .
Hyodo I, Suzuki H, Takahashi K, Saito Y, Tanaka S, Chiu HM, et al. Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol. 2010;40(Suppl 1):i38–43.
Hasan F, Mahmood Shah SM, Munaf M, Khan MR, Marsia S, Haaris SM, et al. Barriers to colorectal cancer screening in Pakistan. Cureus. 2017;9:e1477.
Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014;80:412–7.
Sankaranarayanan R, Ramadas K, Qiao YL. Managing the changing burden of cancer in Asia. BMC Med. 2014;12:3.
Moghimi-Dehkordi B, Safaee A. An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointest Oncol. 2012;4:71–5.
Magaji BA, Moy FM, Roslani AC, Law CW. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital. BMC Cancer. 2017;17:339.
Pathy S, Lambert R, Sauvaget C, Sankaranarayanan R. The incidence and survival rates of colorectal cancer in India remain low compared with rising rates in East Asia. Dis Colon Rectum. 2012;55:900–6.
Patell R, Karwa A, Lopez R, Burke CA. Poor knowledge of colorectal cancer screening and surveillance guidelines in a national cohort of digestive disease specialists. Dig Dis Sci, 2018: 1–10.
Javanparast S, Ward PR, Carter SM, Wilson CJ. Barriers to and facilitators of colorectal cancer screening in different population subgroups in Adelaide, South Australia. Med J Aust. 2012;196:521–3.
Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005;43:939–44.
Perisetti A, Khan H, George NE, Yendala R, Rafiq A, Blakely S, et al. Colorectal cancer screening use among insured adults: is out-of-pocket cost a barrier to routine screening? World J Gastrointest Pharmacol Ther. 2018;9:31–8.
Veettil SK, Lim KG, Chaiyakunapruk N, Ching SM, Abu Hassan MR. Colorectal cancer in Malaysia: its burden and implications for a multiethnic country. Asian J Surg. 2017;40:481–9.
Goh KL, Quek KF, Yeo GT, Hilmi IN, Lee CK, Hasnida N, et al. Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther. 2005;22:859–64.
Shah SA, Neoh HM, Rahim S, Azhar ZI, Hassan MR, Safian N, et al. Spatial analysis of colorectal cancer cases in Kuala Lumpur. Asian Pac J Cancer Prev. 2014;15:1149–54.
• de Klerk CM, Gupta S, Dekker E, Essink-Bot ML, Expert Working Group. ‘Coalition to reduce inequities in colorectal cancer screening’ of the World Endoscopy O. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut. 2018;67:679–87. Socioeconomic and ethnic challenges for an effective organized screening program.
Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology. 2010;138:2115–26.
Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008;57:1166–76.
GovHK. Colorectal cancer screening programme starts today. 2018 [cited 2019 January 11]; Available from: https://www.info.gov.hk/gia/general/201808/06/P2018080300587.htm .
Khuhaprema T, Sangrajrang S, Lalitwongsa S, Chokvanitphong V, Raunroadroong T, Ratanachu-Ek T, et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open. 2014;4:e003671.
Sarakarn P, Promthet S, Vatanasapt P, Tipsunthonsak N, Jenwitheesuk K, Maneenin N, et al. Preliminary results: colorectal cancer screening using fecal immunochemical test (FIT) in a Thai population aged 45-74 years: a population-based randomized controlled trial. Asian Pac J Cancer Prev. 2017;18:2883–9.
Sarakarn P, Suwanrungruang K, Vatanasapt P, Wiangnon S, Promthet S, Jenwitheesuk K, et al. Joinpoint analysis trends in the incidence of colorectal cancer in Khon Kaen, Thailand (1989 - 2012). Asian Pac J Cancer Prev. 2017;18:1039–43.
Quach DT, Hiyama T, Nguyen TA, Ly HQ, Tanaka S. Asia-Pacific colorectal screening score: a useful tool to stratify risk for colorectal advanced neoplasms in Vietnamese patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2018;33:150–5.
Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016–30.
Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–41.
Chiu HM, Ching JY, Wu KC, Rerknimitr R, Li J, Wu DC, et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016;150:617–25 e3.
Cha JM, Suh M, Kwak MS, Sung NY, Choi KS, Park B, et al. Risk of interval cancer in fecal immunochemical test screening significantly higher during the summer months: results from the National Cancer Screening Program in Korea. Am J Gastroenterol. 2018;113:611–21.
Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147:1317–26.
•• Chiu SY, Chuang SL, Chen SL, Yen AM, Fann JC, Chang DC, et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut. 2017;66:293–300. The need for endoscopy quality assurance.
Matsuda K, Tanaka K, Fujishiro M, Saito Y, Ohtsuka K, Oda I, et al. Design paper: Japan Endoscopy Database (JED): a prospective, large database project related to gastroenterological endoscopy in Japan. Dig Endosc. 2018;30:5–19.
JGES. Japan Endoscopic Database (JED) Project. JED Project 2015 [cited 2019 January 4]; Available from: https://www.jges.net/jedproject/ .
Lee BI, Hong SP, Kim SE, Kim SH, Kim HS, Hong SN, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45:25–43.